Dengue among Patients Visiting Department of Medicine in a Secondary Care Centre: A Descriptive Cross-sectional Study
- PMID: 40802723
- PMCID: PMC10395585
- DOI: 10.31729/jnma.8206
Dengue among Patients Visiting Department of Medicine in a Secondary Care Centre: A Descriptive Cross-sectional Study
Abstract
Introduction: Dengue, caused by the dengue virus, has a wide range of clinical features, including fever, body ache, lethargy, nausea, and vomiting. Blood-based biomarkers in patients with dengue virus infection reflect a variety of clinical spectrums, from bleeding manifestations to liver abnormalities, and can serve as an essential tool for clinicians. This study aimed to determine the prevalence of dengue among patients visiting the Outpatient Department in a secondary care centre.
Method: A descriptive cross-sectional study was conducted among patients visiting the Outpatient Department from 16 May 2022 to 15 November 2022. Ethical approval was obtained from the Institutional Review Committee (Reference number: 20790202). The socio-demographic details and biochemical and haematological findings of dengue virus-infected patients diagnosed with rapid diagnostic tests were collected. Convenience sampling was done. Point estimate and 95% Confidence Interval were calculated.
Results: Out of 706 individuals, the prevalence of dengue was 83 (11.76%) (9.38-14.14, 95% Confidence Interval). The median age of dengue virus-infected patients was 40 years, and the majority were males 54 (65.06%).
Conclusions: The prevalence of dengue was found to be lower than in other studies done in similar settings.
Keywords: Nepal; biomarkers; dengue; prevalence; prognosis.
© The Author(s) 2023.
Conflict of interest statement
None.
Similar articles
-
Scrub Typhus among Febrile Patients Admitted to the Department of Medicine in a Tertiary Care Centre: A Descriptive Cross-sectional Study.JNMA J Nepal Med Assoc. 2023 Jul;61(263):576-579. doi: 10.31729/jnma.8208. Epub 2023 Jul 30. JNMA J Nepal Med Assoc. 2023. PMID: 40802744 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Microalbuminuria among Patients with Diabetes Mellitus Visiting the Department of Nephrology in a Tertiary Care Centre: A Descriptive Cross-sectional Study.JNMA J Nepal Med Assoc. 2023 Jul;61(263):596-598. doi: 10.31729/jnma.8214. Epub 2023 Jul 30. JNMA J Nepal Med Assoc. 2023. PMID: 40802713 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
References
-
- Ferede G, Tiruneh M, Abate E, Wondimeneh Y, Gadisa E, Howe R, et al. A study of clinical, hematological, and biochemical profiles of patients with dengue viral infections in Northwest Ethiopia: implications for patient management. BMC Infect Dis. 2018 Dec 4;18(1):616. doi: 10.1186/s12879-018-3557-z. - DOI - PMC - PubMed
-
- Rai SK, Rai JR. Largest dengue outbreak (2022) in Nepal. Nepal Med Coll J. 2023 Mar 21;25(1):73–8. doi: 10.3126/nmcj.v25i1.53383. - DOI
-
- Shekar GC, Amaravadi A. Clinical, biochemical and hematological profile in dengue fever. Int J Sci Study. 2016 Oct;4(7):144–9.
-
- Saud B, Adhikari S, Maharjan L, Paudel G, Amatya N, Amatya S. An epidemiological prospective of focal outbreak of dengue infection in Kathmandu, Nepal. J Clin Virol Plus. 2022 Feb 1;2(1):100063. doi: 10.1016/j.jcvp.2022.100063. - DOI
LinkOut - more resources
Full Text Sources